Insights

  • Date

  • Content Type

  • Reset

White Paper

Cell & Gene Therapy: Maximizing Commercialization Potential

28.06.23
How to Navigate the Less Obvious Barriers to Brining Advanced & Highly Targeted Treatments to
Read More

White Paper

Science Huddle – SMALL DATA, BIG OUTCOMES

26.01.23
With the reach and impact of biopharma growing exponentially, experts in biotech and the evolving
Read More

White Paper

The Future of Advanced Therapies: Strategies to Evolve Global Health in a Post-COVID World

1.10.21
Driven by scientific innovations and impressive clinical outcomes, next-generation therapies are on the threshold of
Read More

We are now Cencora PharmaLex 

PharmaLex is now part of Cencora, a leading global healthcare company with a foundation in pharmaceutical distribution. In 2024 and beyond PharmaLex and all the companies in PharmaLex family will begin a journey to becoming Cencora as well. Cencora brings the companies and services together under one new name. The name will change, but the level of attention and service you receive remains the same.  

Know more